Skip to main content
. 2023 Aug 11;13:13048. doi: 10.1038/s41598-023-40088-7

Table 2.

The demographic and clinical characteristics of cirrhotic patients with and without AKI during the six-month follow-up period.

AKI Non-AKI Total p
n = 13 (18.6%) n = 57 (81.4%) n = 70
Age (mean ± SD) 71.1 (12.0) 59.2 (11.2) 61.4 (12.2) 0.001
Male, n (%) 9 (69.2) 48 (84.2) 57 (81.4) 0.24
Etiology of cirrhosis, n (%)
 Hepatitis B 2 (15.4) 40 (70.2) 42 (62) < 0.001
 Hepatitis C 5 (38.5) 16 (28.1) 21 (30) 0.51
 Alcohol 5 (38.5) 20 (35.1) 25 (35.7) 1
 Others 3 (23.1) 2 (3.5) 5 (7.1) 0.04
Laboratory data (mean ± SD)
 White blood cell count (/μL) 5823.1 (2396.2) 4736.3 (1734.2) 4938.1 (1902.8) 0.22
 Platelet count (/μL) 136,384.6 (110,508.3) 101,403.5 (51,916.4) 107,900 (67,075.2) 0.56
 INR 1.2 (0.2) 1.3 (0.3) 1.3 (0.2) 0.84
 Sodium (mEq/L) 137.4 (4.9) 136.8 (3.8) 136.9 (4.0) 0.35
 sCr (mg/dL) 0.9 (0.3) 1 (0.6) 1 (0.5) 0.85
 eGFR (mL/min/1.73 m2) 80.2 (41.0) 90.4 (31.1) 88.9 (32.6) 0.37
 Albumin (g/dL) 3.2 (0.6) 3.3 (0.6) 3.3 (0.6) 0.86
 Total bilirubin (mg/dL) 2.4 (2.0) 3.2 (6.7) 3.1 (6.1) 0.35
 C-reactive protein (mg/dL) 5.2 (4.2) 3.4 (4.9) 3.7 (4.8) 0.03
 MELD-Na score 10.9 (7.1) 9.9 (8.8) 10.1 (8.5) 0.43
 Child Pugh score 7.8 (1.7) 7.2 (1.9) 7.3 (1.9) 0.16
 FIB-4 index 10.7 (7.2) 10.4 (15.0) 10.4 (14.1) 0.33
 Zonulin (ng/mL) 7.1 (1.7) 4.7 (1.4) 5.1 (1.8) < 0.001
 LPS (ng/mL) 3.2 (1.3) 2.2 (0.9) 2.4 (1.1) 0.02
 LBP (ng/mL) 92.2 (20.2) 72.7 (21.3) 76.3 (22.3) 0.004
Clinical events at admission, n (%)
 Ascites 8 (61.5) 22 (38.6) 30 (42.9) 0.21
 Spontaneous bacterial peritonitis 1 (7.7) 4 (7.0) 5 (7.1) 1
 Encephalopathy 1 (7.7) 4 (7.0) 5 (7.1) 1
 Esophageal varices bleeding 0 6 (10.5) 6 (8.6) 0.58
 Sepsis 4 (30.8) 5 (8.8) 9 (12.9) 0.05
 Septic shock 0 3 (5.3) 3 (4.3) 1
 Acute on chronic liver failure 3 (23.1) 13 (22.8) 16 (22.9) 1

Chi-squared tests and Fisher’s exact tests were used for categorical variables. T-tests and Mann–Whitney U tests were used for continuous variables.

AKI acute kidney injury, eGFR estimated glomerular filtration rate, FIB-4 index Fibrosis-4 index, HRS hepatorenal syndrome, INR international normalized ratio, LBP lipopolysaccharide-binding protein, LPS lipopolysaccharides, MELD-Na score model for end-stage liver disease score incorporating sodium, sCr serum creatinine, SD standard deviation.